Imrecoxib attenuates bleomycin-induced pulmonary fibrosis in mice

Imrecoxib attenuates bleomycin-induced pulmonary fibrosis in mice

Idiopathic pulmonary fibrosis (IPF) is an incurable chronic progressive disease with a low survival rate and ineffective therapeutic options. We examined the effects of imrecoxib, a nonsteroidal anti-inflammatory drug, on experimental pulmonary fibrosis. The mouse IPF model was established by intrat...

Full description

Bibliographic Details
Main Authors: Yang Miao, Yue Yang, Xiaohe Li, Lingxin Meng, Jiahe Mao, Jianwei Zhang, Jingjing Gao, Cheng Yang, Xiaoting Gu, Honggang Zhou, Yanping Zhang
Format: Article
Language:English
Published: Elsevier 2023-11-01
Series:Heliyon
Subjects:
Idiopathic pulmonary fibrosis
Imrecoxib
Inflammation
TGF-β1
ERK1/2
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844023081227

Internet

http://www.sciencedirect.com/science/article/pii/S2405844023081227

Similar Items